Abstract
A tetracycline (Tc)-controlled gene expression system that quantitatively controls gene expression in eukaryotic cells (Gossen and Bujard, 1992) was used to express cytochrome P-450 2E1 (CYP2E1) in HeLa cells in culture. The rabbit CYP2E1 cDNA was subcloned into the Tc-controlled expression vector (pUHD10–3) and transfected into a HeLa cell line constitutively expressing the Tc-controlled transactivator, a positive regulator of expression in the absence of Tc. The expression of CYP2E1 was tightly regulated. There was a time-dependent induction of CYP2E1 after removal of Tc. In the absence of Tc, the enzyme was induced more than 100-fold and expressed about 18 pmol of CYP2E1/mg microsomal protein. At maximal levels of expression the enzyme catalyzed the formation of 158 pmol 6-hydroxychlorzoxazone/min/mg total cellular protein. In addition, the level of the enzyme could be modulated by the concentration of Tc in the media. In the absence of Tc, exposure of cells toN-nitrosodimethylamine caused a significant dose-dependent decrease in cell viability. In contrast, menadione, a redox cycling toxicant, was less toxic to the cells after induction of CYP2E1 when compared with noninduced cells. Pulse-chase studies conducted 72 h after removal of Tc indicated a rapid turnover of CYP2E1 with a half-life of 3.9 h. Addition of the ligand, 4-methylpyrazole, and the suicide substrate, 1-aminobenzotrizole, decreased the degradation of CYP2E1. This cell line offers a useful system to examine the role of CYP2E1 in the cytotoxicity of xenobiotics and to investigate post-translational regulation of the enzyme.
Footnotes
-
Send reprint requests to: Dr. Dennis R. Koop, Department of Physiology and Pharmacology, L334, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97201. E-mail: koopd{at}ohsu.edu
-
Supported by National Institute on Alcohol Abuse and Alcoholism Grants AA08608 and AA05462.
- Abbreviations used are::
- CYP2E1
- cytochrome P-450 2E1
- Tc
- tetracycline
- 6-OH-CZ
- 6-hydroxychlorzoxazone
- MTT
- 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- NDMA
- N-nitrosodimethylamine
- 4MP
- 4-methylpyrazole
- ABT
- 1-aminobenzotriazole
- DCF
- 2′,7′-dichlorofluorescein
- H2DCFDA
- 2′,7′-dichlorodihydrofluorescein diacetate
- tTA
- Tc-controlled transactivator
- tetR
- tetracycline repressor protein
- DMEM
- Dulbecco’s modified Eagle’s medium
- ROS
- reactive oxygen species
- Received November 19, 1997.
- Accepted December 23, 1998.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|